{"url_path":"/sec/pavm/10-q/2026/item-5","section_key":"item-5","section_title":"Item 5 Other Information**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/1624326/0001437749-26-017121-index.html","accession_number":"0001437749-26-017121","cik":"0001624326","ticker":"PAVM","issuer_name":"PAVmed Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1624326/0001437749-26-017121-index.html","primary_entity_key":"0001624326","primary_entity_name":"PAVmed Inc."},"word_count":55,"has_tables":true,"body_markdown":"**Item 5. Other Information**\n\n \n\nDuring the fiscal quarter ended *March 31, 2026*, none of our directors or officers (as defined in Rule *16a*-*1* under the Exchange Act) adopted or terminated a “Rule *10b5*-*1* trading arrangement” or “non-Rule *10b5*-*1* trading arrangement” (as those terms are defined in Item *408* of Regulation S-K).\n\n \n\n \n\n42\n\n[Table of Contents](#toc)"}